USAS Building System Listed on the Hong Kong Stock Exchange: A Top-Three Industrial Prefabricated Steel Structure Solution Provider Enters a New Phase in the Capital Markets 
DEFSEC Technologies Inc. Announces Full Year Fiscal 2025 Results and Outlook for Fiscal 2026 
The FUTR Corporation Announces Enterprise Agreement with Direct Wholesale Rates to Expand AI-Powered Mortgage, Payments, and Home Concierge Services in the U.S. 
Pineapple Financial Appoints Anthony Georgiades to Board of Directors and Special Advisory Committee 
Gatekeeper Reports $31.8M Revenue in Fiscal 2025 Adaptimmune to Present First Preclinical Data from its HLA-independent TCR (HiT) Platform at ASGCT
PHILADELPHIA and OXFORDSHIRE, United Kingdom, April 27, 2021 (GLOBE NEWSWIRE) — Adaptimmune Therapeutics plc (Nasdaq:ADAP),…
Codiak to Present Preclinical Data Demonstrating Broad Potential Applications for Engineered Exosomes at the American Society for Gene and Cell Therapy (ASGCT) Annual Meeting
– engEx™ Platform and in vitro and in vivo findings support utility across multiple therapeutic…
Sigilon Therapeutics Announces Presentations at the American Society of Gene and Cell Therapy 24th Annual Meeting
Presentations include initial results from preclinical studies of expanded pipeline programs in immune-mediated and metabolic…
Affinia Therapeutics to Present New Data and Updates on AAV Platform at the American Society of Gene and Cell Therapy Annual Meeting
WALTHAM, Mass., April 27, 2021 (GLOBE NEWSWIRE) — Affinia Therapeutics, an innovative gene therapy company…
Pacific Biosciences Nominates Dr. Hannah Valantine to its Board of Directors
MENLO PARK, Calif., April 27, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:…
Orphazyme to present at upcoming investor conferences
Orphazyme A/SInvestor news No. 05/2021Company Registration No. 32266355 Copenhagen, Denmark and Chicago, IL, USA, April 27, 2021…
Athenex to Provide Corporate and Financial Update for the First Quarter 2021 on May 6, 2021
BUFFALO, N.Y., April 27, 2021 (GLOBE NEWSWIRE) — Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical…
Adaptive Biotechnologies to Present at the BofA Securities 2021 Virtual Healthcare Conference
SEATTLE, April 27, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a commercial stage…
Tarsus Pharmaceuticals, Inc. to Present at the BofA Securities 2021 Virtual Health Care Conference
IRVINE, Calif., April 27, 2021 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late…
Myriad Genetics to Release March 2021 Quarterly Financial Results on May 3, 2021, Host Investor Day on May 4, 2021
SALT LAKE CITY, April 27, 2021 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a…
BioVie Acquires Biopharma Assets from Privately Held NeurMedix
Includes Pivotal Phase 3 Alzheimer’s Asset NE3107 Cuong V. Do Named CEO of The New…
Leading BioSciences Closes Merger with Seneca Biopharma and Set to Begin Trading on Nasdaq as PALI
The combined company, Palisade Bio, Inc., is expected to commence trading on the Nasdaq Capital…
Gain Therapeutics to Present at the B. Riley Securities’ Virtual Neuroscience Conference
BETHESDA, Md., April 27, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (NASDAQ: GANX) (“Gain”) a…
Y-mAbs Submits Omburtamab Marketing Authorization Application to the European Medicines Agency
NEW YORK, April 27, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq:…
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2021 Financial Results
– Granted Priority Medicines designation by the European Medicines Agency for CTX001™ for transfusion-dependent beta…
Aligos Therapeutics Appoints James Scopa, J.D., MBA, to its Board of Directors
SOUTH SAN FRANCISCO, Calif., April 27, 2021 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS),…
Iovance Biotherapeutics to Host First Quarter Financial Results Conference Call and Webcast on Thursday, May 6, 2021
SAN CARLOS, Calif., April 27, 2021 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a…
Santhera Reports End Results on Convertible Bond Exchange Offer
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL…
Resverlogix’s Apabetalone Demonstrates a Medical First in Patients with Chronic Kidney Disease
Apabetalone treatment was associated with a 52% hazard reduction for MACE events such as CVD…
CORRECTION: Composition of the Nomination Committee of Orion Corporation
ORION CORPORATION STOCK EXCHANGE RELEASE 27 APRIL 2021 at 19.50 EEST CORRECTION: Composition of the Nomination…